Literature DB >> 15793159

Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.

Ad C Fluit1, Alice Florijn, Jan Verhoef, Dana Milatovic.   

Abstract

No relation between the presence of tetracycline resistance determinants tet(A) to tet(E) and the MICs of tigecycline was observed for Enterobacteriaceae, although tetracycline-susceptible isolates were more susceptible overall to tigecycline, whereas the presence of tet(M) in Staphylococcus aureus was associated with higher MICs of minocycline.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793159      PMCID： PMC1068614          DOI： 10.1128/AAC.49.4.1636-1638.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates.

Authors:  F J Schmitz; A Krey; R Sadurski; J Verhoef; D Milatovic; A C Fluit
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

2.  Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus.

Authors:  K Trzcinski; B S Cooper; W Hryniewicz; C G Dowson
Journal:  J Antimicrob Chemother       Date:  2000-06       Impact factor: 5.790

3.  Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.

Authors:  M Tuckman; P J Petersen; S J Projan
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

4.  Gene heterogeneity for tetracycline resistance in Staphylococcus spp.

Authors:  R Bismuth; R Zilhao; H Sakamoto; J L Guesdon; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

5.  Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.

Authors:  B A Rasmussen; Y Gluzman; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 6.  Glycylcyclines: a new generation of tetracyclines.

Authors:  F T Tally; G A Ellestad; R T Testa
Journal:  J Antimicrob Chemother       Date:  1995-04       Impact factor: 5.790

7.  Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.

Authors:  P E Sum; P Petersen
Journal:  Bioorg Med Chem Lett       Date:  1999-05-17       Impact factor: 2.823

8.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 9.  The glycylcyclines: a comparative review with the tetracyclines.

Authors:  George G Zhanel; Kristen Homenuik; Kim Nichol; Ayman Noreddin; Lavern Vercaigne; John Embil; Alfred Gin; James A Karlowsky; Daryl J Hoban
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis.

Authors:  Melissa A Visalli; Ellen Murphy; Steven J Projan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more
  27 in total

1.  Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections.

Authors:  C Hal Jones; Margareta Tuckman; Anita Y M Howe; Mark Orlowski; Stanley Mullen; Karen Chan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Diverse tetracycline resistant bacteria and resistance genes from coastal waters of Jiaozhou Bay.

Authors:  Hongyue Dang; Jing Ren; Linsheng Song; Song Sun; Liguo An
Journal:  Microb Ecol       Date:  2007-08-01       Impact factor: 4.552

3.  Mutations at the Ribosomal S10 Gene in Clinical Strains of Staphylococcus aureus with Reduced Susceptibility to Tigecycline.

Authors:  M Angeles Argudín; S Roisin; M Dodémont; C Nonhoff; A Deplano; O Denis
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 4.  The tetracycline resistome.

Authors:  Maulik Thaker; Peter Spanogiannopoulos; Gerard D Wright
Journal:  Cell Mol Life Sci       Date:  2009-10-28       Impact factor: 9.261

5.  Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.

Authors:  María-Isabel Morosini; María García-Castillo; Teresa M Coque; Aránzazu Valverde; Angela Novais; Elena Loza; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 6.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany.

Authors:  M Kresken; K Becker; H Seifert; E Leitner; B Körber-Irrgang; C von Eiff; P-A Löschmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-24       Impact factor: 3.267

8.  Optimization of 4-Substituted Benzenesulfonamide Scaffold To Reverse Acinetobacter baumannii Serum-Adaptive Efflux Associated Antibiotic Tolerance.

Authors:  Michaelle Chojnacki; Xufeng Cao; Mikaeel Young; Rebecca N Fritz; Paul M Dunman; Daniel P Flaherty
Journal:  ChemMedChem       Date:  2020-08-13       Impact factor: 3.466

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program report.

Authors:  Jan M Bell; John D Turnidge; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2009-05-20       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.